Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shu Gan Yi Yang Capsule for Depression Associated with Erectile Dysfunction
NCT03290313Phase 4Unknown
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Sep 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and erectile dysfunction (ED) comparing Shu Gan Yi Yang Capsule with Placebo (2 arms). Primary endpoints: International Index of Erectile Function at 8 weeks and Montgomery Depression Rating Scale at 8 weeks. Status: unknown.
02
Drugs
Shugan Yiyang capsule
03
Conditions
major depressive disorder (MDD)erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03290313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290313.